Genentech, Inc. $RO.SW
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS14
PHASE 3 / 2-32
RECRUITING7
READOUTS ≤12 MONTHS5
READOUT SLIPPED >6 MO56%
Delay Index: of 9 active trials registered more than a year ago, 5 have moved their primary completion (readout) date by more than 6 months since first registration (median +7.4 months). See all sponsors →
Open Genentech, Inc. on the live radar map → 📅 $RO.SW readout calendar (.ics)| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| Giredestrant NCT05306340 |
P3 | Active, not recruiting | Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer | 373 | 2025-07-16 (+11 mo) |
| BRAVE NCT06524375 |
P2 | Active, not recruiting | Chronic Lymphocytic Leukemia | 118 | 2026-10-28 (-3 mo) |
| NAUTIKA1 NCT04302025 |
P2 | Active, not recruiting | Non-small Cell Lung Cancer | 99 | 2026-11-30 (-14 mo) |
| Docetaxel NCT00781612 |
P2 | Active, not recruiting | Neoplasm Metastasis | 378 | 2027-06-30 |
| Kirros NCT06096779 |
P2 | Active, not recruiting | Hepatocellular Carcinoma | 30 | 2027-07-30 (+15 mo) |
| MorningSun NCT05207670 |
P2 | Active, not recruiting | Non-Hodgkin Lymphoma | 320 | 2027-07-31 (+7 mo) |
| RO7837195 NCT06979336 |
P2 | Recruiting | Ulcerative Colitis | 224 | 2027-08-25 |
| GDC-1261 NCT07567846 |
P1/2 | Recruiting | Advanced Prostate Cancer; Metastatic Prostate Cancer | 260 | 2027-11-30 |
| RIVULET NCT07448038 |
P2 | Recruiting | Atherosclerosis | 162 | 2028-01-31 |
| MoonROSE NCT07100106 |
P1/2 | Recruiting | Breast Cancer | 285 | 2028-08-31 (-23 mo) |
| RO7965032 NCT07851259 |
P2 | Recruiting | Geographic Atrophy Secondary to Age-Related Macular Degeneration | 321 | 2030-08-21 |
| IMCODE003 NCT05968326 |
P2 | Active, not recruiting | Adenocarcinoma, Pancreatic Ductal | 260 | 2031-01-01 (+19 mo) |
| OpRegen NCT05626114 |
P2 | Recruiting | Geographic Atrophy | 60 | 2031-03-01 (+17 mo) |
| Giredestrant NCT07541079 |
P3 | Recruiting | Early Breast Cancer | 300 | 2032-06-30 |